Drugmaker Pfizer has launched a mobile application designed to streamline enrolment into its patient access programs (PAP).
Pfizer runs over 10 programs supporting patients with its treatments, the company said on the development that comes days after another multinational, Roche, made a similar announcement.
In this case too, PAP is being executed by Tata 1MG (MediAngels by TATA 1MG), Pfizer India said. The programme offers eligible patients therapy assistance, based on a valid prescription by the treating physician and the submission of other required documents by the patient.
“Improving access to our medicines via PAPs and providing information and support services ecosystem to help patients follow through in their treatment journey is our goal,” said Satyen Amin, Director (Commercial Channel and Market Access), Pfizer India. Patients can enroll in the program by uploading the required documents.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.